TY - JOUR
T1 - Radiofrequency thermal ablation of renal graft neoplasms
T2 - A literature review
AU - Iezzi, Roberto
AU - Posa, Alessandro
AU - Carchesio, Francesca
AU - Romagnoli, Jacopo
AU - Salerno, Maria Paola
AU - Citterio, Franco
AU - Manfredi, Riccardo
N1 - Copyright © 2019 Elsevier Inc. All rights reserved.
PY - 2019/7
Y1 - 2019/7
N2 - Neoplasms occurring in renal grafts represent a relatively novel and rare condition, whose treatment has not been standardized yet. Radiofrequency thermal ablation (RFA) of renal graft neoplasms is a nephron-sparing treatment, reported to be safe and effective. However, even in the RFA field, there is no procedural standardization. In this review of the literature, mostly composed by case reports and case series, we aim to assess efficacy and complication rates of RFA in the treatment of kidney graft neoplasms, and summarize the various procedural protocols found in the literature, using an easy-to-read point format. We performed a literature search in PubMed/MEDLINE with an overall description of 66 renal graft lesion treated with RFA, with a mean follow-up of 16.3 months (range 3-54.3). Technical success was achieved in all cases, with only one recurrence reported (1/66; 1.5%), occurring at 6-months follow-up. Complications occurred in 11 (11/66; 16.7%) patients. Based on literature review, RFA of renal graft neoplasms seems to be a feasible, safe, and effective treatment.
AB - Neoplasms occurring in renal grafts represent a relatively novel and rare condition, whose treatment has not been standardized yet. Radiofrequency thermal ablation (RFA) of renal graft neoplasms is a nephron-sparing treatment, reported to be safe and effective. However, even in the RFA field, there is no procedural standardization. In this review of the literature, mostly composed by case reports and case series, we aim to assess efficacy and complication rates of RFA in the treatment of kidney graft neoplasms, and summarize the various procedural protocols found in the literature, using an easy-to-read point format. We performed a literature search in PubMed/MEDLINE with an overall description of 66 renal graft lesion treated with RFA, with a mean follow-up of 16.3 months (range 3-54.3). Technical success was achieved in all cases, with only one recurrence reported (1/66; 1.5%), occurring at 6-months follow-up. Complications occurred in 11 (11/66; 16.7%) patients. Based on literature review, RFA of renal graft neoplasms seems to be a feasible, safe, and effective treatment.
KW - Catheter Ablation
KW - Humans
KW - Kidney Neoplasms/etiology
KW - Kidney Transplantation/adverse effects
U2 - 10.1016/j.trre.2019.01.002
DO - 10.1016/j.trre.2019.01.002
M3 - Review article
C2 - 30824192
VL - 33
SP - 161
EP - 165
JO - Transplantation Reviews
JF - Transplantation Reviews
SN - 0955-470X
IS - 3
ER -